3 Articles
3 Articles
Tom Brady-backed eMed rides GLP-1 success to a $200M Series A at a $2B valuation
Miami-based eMed, a digital health company that manages GLP-1 weight-loss programs for employers, just announced it has raised $200 million in Series A funding at a valuation of over $2 billion. The round brings together lead investor AON Consulting and NFL legend Tom Brady, who was also named eMed’s Chief Wellness Officer. eMed CEO Linda Yaccarino, who was named to eMed’s top post last August, participated in the round, too. Paragon Bioscienc…
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium



